Video could not be played
iPSC Unit
The Human Induced Pluripotent Stem Cell (iPSC) unit is dedicated to the generation, characterization, and application of human iPSC models. The unit provides an integrated end-to-end pipeline for reprogramming somatic cells into pluripotent stem cells and directing their differentiation into physiologically relevant cell types. With a strong focus on quality, reproducibility, and translational relevance, the facility supports the development of robust patient-derived models that advance discovery in disease modeling, drug screening, and regenerative medicine.
Services
- iPSC Generation & Banking: Reprogramming of somatic cells into human iPSC lines, followed by expansion, validation, and long-term cryopreservation of established iPSC lines.
- Characterization & Quality Control: Assessment of pluripotency, genomic stability, and differentiation potential of iPSC lines.
- Differentiation Platforms: Generation of iPSC-derived key cell types including hematopoietic stem/progenitor cells (HSPCs), neurons, cardiomyocytes, hepatocytes, and immune cells.
- Disease Modeling & Genome Editing: Development of patient-derived and CRISPR/Cas9- genome engineered iPSC models for functional studies.
- Consultation & Experimental Support: Training and technical support in human iPSC culture, characterization, and differentiation workflows. Guidance on study design and translational applications.